ASMB
NASDAQ · Biotechnology
Assembly Biosciences Inc
$28.58
+0.12 (+0.42%)
Open$29.10
Previous Close$28.46
Day High$30.18
Day Low$27.53
52W High$39.71
52W Low$7.75
Volume—
Avg Volume108.4K
Market Cap410.77M
P/E Ratio—
EPS$-4.81
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
-61.8% upside
Current
$28.58
$28.58
Target
$10.92
$10.92
$9.01
$10.92 avg
$17.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 70.46M | 42.49M | 300.07M |
| Net Income | -99,260,044 | -53,870,855 | 8.49M |
| Profit Margin | -140.9% | -133.8% | 2.8% |
| EBITDA | -111,894,705 | -64,101,772 | 15.38M |
| Free Cash Flow | — | — | 12.77M |
| Rev Growth | +65.8% | +65.8% | +3.4% |
| Debt/Equity | — | — | 0.84 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |